- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
May 4th, 2007
Midatech Group Ltd. has announced the opening of its specialist design and manufacturing facility for cGMP grade nanoparticles in Bilbao, Spain.
Midatech Biogune S.L. is the world's first cGMP grade manufacturing plant for the production of nanoparticles at a scale commensurate with pharmaceutical applications.
Staffed by an experienced, multi-disciplined team, the plant will initially focus on the design and manufacture of nanoparticles to supply Midatech Group's series of projects applying nanotechnology for therapeutic purposes. These include using nanoparticles as scaffolds for synthetic vaccines and antibiotics, as drug delivery vehicles for RNAi drugs and drugs able to cross the blood brain barrier, as well as targeted cancer treatments and imaging agents. Midatech's nanoparticles will allow drug companies to deliver new and existing medicines at significantly lower doses and with greater specificity, thereby reducing toxicity.
|Related News Press|
Harris & Harris Group Sponsors NYC American Heart Association's Health Sciences Innovation Investment Forum: Co-founder of Harris & Harris Group Portfolio Company TARA Biosystems to Speak About the Value of Tissue Engineering Technology April 21st, 2015
Long Island Capital Alliance Announces Participants for Brookhaven National Laboratory Technology Transfer Capital Forum on May 8: Keynote Speaker Dr. Doon Gibbs, Director of Brookhaven National Laboratory April 16th, 2015
Graphenea embarks on a new era April 16th, 2015